http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
김병수(Byung Soo Kim),이재학(Jea Hack Lee),황태호(Tae Ho Hwang),김동순(Dong Sun Kim) 한국전자통신학회 2018 한국전자통신학회 논문지 Vol.13 No.5
최근 인간의 뇌를 모방하여 정보를 학습하고 처리하는 뉴로모픽 기술에 대한 연구는 꾸준히 진행되고 있다. 뉴로모픽 시스템의 하드웨어 구현은 다수의 간단한 연산절차와 고도의 병렬처리 구조로 구성이 가능하여, 처리속도, 전력소비, 저 복잡도 구현 측면에서 상당한 이점을 가진다. 또한 저 전력, 소형 임베디드 시스템에 적용 가능한 뉴로모픽 기술에 대한 연구가 급증하고 있으며, 정확도 손실 없이 저 복잡도 구현을 위해서는 입력데이터의 차원축소 기술이 필수적이다. 본 논문은 멀티모달 센서 데이터를 처리하기 위해 멀티모달 센서 시스템, 다수의 뉴론 엔진, 뉴론 엔진 컨트롤러 등으로 구성된 경량 인공지능 엔진과 특징추출기를 설계 하였으며, 이를 위한 병렬 뉴론 엔진 구조를 제안하였다. 설계한 인공지능 엔진, 특징 추출기, Micro Controller Unit(MCU)를 연동하여 제안한 경량 인공지능 엔진의 성능 검증을 진행하였다. The neuromorphic technology has been researched for decades, which learns and processes the information by imitating the human brain. The hardware implementations of neuromorphic systems are configured with highly parallel processing structures and a number of simple computational units. It can achieve high processing speed, low power consumption, and low hardware complexity. Recently, the interests of the neuromorphic technology for low power and small embedded systems have been increasing rapidly. To implement low-complexity hardware, it is necessary to reduce input data dimension without accuracy loss. This paper proposed a low-complexity artificial intelligent engine which consists of parallel neuron engines and a feature extractor. A artificial intelligent engine has a number of neuron engines and its controller to process multimodal sensor data. We verified the performance of the proposed neuron engine including the designed artificial intelligent engines, the feature extractor, and a Micro Controller Unit(MCU).
Mycobacterium abscessus 폐질환 치료의 장기 성적
조경욱 ( Kyung Uk Jo ),박수정 ( Soo Jung Park ),홍석찬 ( Seok Chan Hong ),오연목 ( Yeon Mok Oh ),이상도 ( Sang Do Lee ),김우성 ( Woo Sung Kim ),김동순 ( Dong Soon Kim ),김원동 ( Won Dong Kim ),심태선 ( Tae Sun Shim ) 대한결핵 및 호흡기학회 2007 Tuberculosis and Respiratory Diseases Vol.62 No.2
연구배경: M. abscessus 폐질환은 최근 우리나라에서 유병률이 증가하는 질환이다. 국내 M. abscessus 폐감염증에 대한 치료성적 및 치료 후 장기결과에 대해서 알아보고자 의무기록을 후향적으로 분석하였다. 방법: 1996년부터 2003년까지 서울아산병원에서 미국흉부학회진단기준에 부합하는 35명의 M. abscessus 폐질환 환자 중 치료를 받은 29명의 환자를 대상으로 임상적 특징과 치료, 치료 후 추적결과에 대해 분석하였다. 결과: 29명의 평균 나이는 56.1세(± 13.6)였고 여성이 76% 이었으며(22/29), 20명(69%)에서 결절 기관지확장증형이었다. 29명 중 19명(65.5%)에서 치료성공하였고 9명(31%)은 치료실패하였다. 1명은 약물부작용으로 치료를 중단하였다. 치료성공군은 중앙값 543일(범위 176 - 1,160)동안 치료를 받았고, 균배양 음전까지의 기간은 중앙값 42일(범위 15-362)이었다. 수술은 5명에서 시행되었으며 한 엽에만 국한된 병변을 가진 두 환자에서 치료성공하였다. 치료 완료 후 중앙값 931일 (범위 230-2294일)동안 추적관찰이 이루어졌고, 19명 중 1명(5.3%)이 재발하였다. 결론: M. abscessus 폐질환의 세균학적 치료 성적은 외국의 보고에 비하여 우수한 편이며 치료성공 후 재발률은 낮았다. Background: Although there is an increasing incidence of Mycobacterium abscessus pulmonary disease in Korea, the optimal therapeutic regimen has not yet been established and there are no reports of the long-term treatment outcomes. This study examined the long-term treatment outcomes of M. abscessus pulmonary disease. Methods: Twenty-nine patients diagnosed with M. abscessus pulmonary according to the American Thoracic Society criteria and treated from January 1996 to December 2003 were enrolled in ghis study. The clinical characteristics, radiological findings, treatment outcome, and follow up data were analyzed retrospectively. Results: The mean age of the 29 patients was 56.1 (± 13.6) years and there was a female (22/29) dominance. The chest radiography revealed the nodular bronchiectatic type to be dominant (69%, 20/29). Twenty-seven (93.1%) were prescribed clarithromycin-containing regimens, and injectable drugs, mainly aminoglycosides, were included in the regimen of nineteen patients. The most predominant regimen (48.3%) consisted of clarithromycin and amikacin. The treatment success, failure, and default were achieved in 19(65.5%), 9(31.0%), and 1(3.4%), respectively. The median duration to culture conversion was 42 days (range 15-362) and the median duration of treatment in the success group was 543 days (range 176-1,160). An adjunctive surgical resection was performed in five patients, which resulted in treatment success in two patients. After the completion of treatment, nineteen patients were followed up for a median duration of 931 days (range 230-2,294). Only one (5.3%) patient relapsed 45 days after completing treatment. Conclusion: Treatment with clarithromycin-containing regimens resulted in a successful treatment in approximately two thirds of patients with M. abscessus pulmonary disease. The long-term relapse rate was also quite low. (Tuberc Respir Dis 2007; 62: 98-104)
폐 유전분증(Amyloidosis)과 다발성 수 (Bullae), 폐 간질내 임파구 침윤이 동반된 Sj$\ddot{o}$gren's 증후군 1예
김동일,임윤정,오영하,김형수,이진성,김동순,Kim, Dong-Il,Lim, Yun-Jeong,Oh, Yung-Ha,Kim, Hyung-Soo,Lee, Jin-Sung,Kim, Dong-Soon 대한결핵및호흡기학회 1997 Tuberculosis and Respiratory Diseases Vol.44 No.6
Sj$\ddot{o}$gren's syndrome(SS) is a chronic inflammatory disorder characterized by lymphocytic infiltration of lacrimal and sailvary glands, which results in dry eyes and dry mouth. SS may exist as a primary condition or as a secondary condition in association with connective tissue disease such as rheumatoid arthritis, systemic lupus erythematosus, or progressive systemic sclerosis. We experienced a patient with primary SS who developed multiple bullae, nodular type of pulmonary amyloidosis and lymphocytic interstitial peumonitis. We believe this to be the first reported case of SS acompanied by these three types pulmonary manifestations at the same time.